Cardiovascular Protective Effect of Spironolactone in Hemodialysis
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to determine if spironolactone is safe and effective in
the treatment of cardiovascular complications in hemodialysis patients.
Phase:
Phase 4
Details
Lead Sponsor:
Universidad de los Andes, Chile Universidad Los Andes, Chile